Skip to content
Review Open access

Between algorithms and humanization

João Rafael Lisboa Rêgo Brito Jussara Secundo dos Santos Letícia Gabriele Secundo dos Santos Sheyla Santana de Almeida Diego Pinto de Oliveira Grace Anne Azevedo Dória
Aug 2026 · Revista Inclusiones · Vol 13, pp. e4003 · 0 citations

TL;DR

Overall, AI emerged as a key driver of innovation in oncological palliative care as well as a strategic tool for supporting decision-making within health systems and identifying emerging technological trajectories.

Abstract

Patent mapping is a strategic tool for supporting decision-making within health systems and identifying emerging technological trajectories. In oncology, the growing demand for palliative care, coupled with rising treatment costs, has intensified interest in artificial intelligence (AI)-based solutions. This study reviewed patents published during the preceding five-year period to characterize AI-related technological trends in oncology, with particular emphasis on their clinical applications and economic implications. Patent searches were conducted in the databases of the Brazilian National Institute of Industrial Property, Espacenet, and the World Intellectual Property Organization between September and December 2025, using the search terms “Palliative Care” and “Cancer,” together with the International Patent Classification code G16H10/60. Of the 251 patents initially identified, 19 met the predefined eligibility criteria. The protected technologies included risk prediction models, clinical decision support systems, symptom-monitoring platforms, and natural language processing tools. These innovations were designed to improve prognostic accuracy, facilitate referrals to palliative care services, and optimize the allocation of healthcare resources. Overall, AI emerged as a key driver of innovation in oncological palliative care.

Read PDF

Similar papers

Review Open access Sep 2026

Mapping the global landscape of artificial intelligence in pancreatic cancer research

Artificial intelligence research in pancreatic cancer is growing rapidly and becoming increasingly multidisciplinary, although productivity and collaboration remain uneven.

Pegah Rashidian, A. Smerat, Mohammad Ahmar Khan et al. · 0 citations
Review Open access Aug 2026

From bedside queries to complex care: AI for decision-making in infectious diseases.

BACKGROUND Infectious Diseases require rapid decisions based on heterogeneous and evolving clinical data. At the same time, the shortage of infectious diseases specialists continues to widen the gap between demand for expertise and its availability. Artificial intelligence (AI) has emerged as a potential support tool,...

Fabio Borgonovo, F. Pennisi, Francesco Petri et al. · 1 citation
Review Aug 2026

From general-purpose models to purpose-built artificial intelligence systems for health economic modeling.

This review examines current applications of LLMs to health economic modeling in terms of reproducibility, validation, adaptability, and technology readiness and concludes that near-term gains are augmenting human modelers on decomposed, verifiable sub-tasks rather than pursuing autonomous end-to-end modeling.

Attila Imre, B. Németh, Á. Jóźwiak et al. · 0 citations
Review Open access Aug 2026

Enhancing Clinical Decision-Making Using Generative AI-Powered Knowledge Retrieval Systems: A Review of Emerging Approaches and Challenges

The study concludes that evidence-based, auditable, locally adaptable, locally adaptable, and supervised by licensed clinician retrieval systems with generative AI can support safer, faster, and more relevant decision-making processes in clinical settings.

Sonam Kumari · 0 citations
Review Open access Aug 2026

Intelligence at Scale: Reimagining Pharmaceutical Market Insight in the Age of AI

Although challenges related to data governance, interoperability, ethical oversight, and workforce preparedness remain, responsible AI adoption supported by robust regulatory frameworks will be critical for sustaining long-term value.

Upendra Nagaich · 0 citations
Review Open access Aug 2026

Artificial intelligence in oncology: linking biological discovery to clinical utility

Artificial intelligence (AI) has expanded rapidly across the oncology continuum—spanning early detection, histopathology, molecular profiling, treatment selection, drug discovery, toxicity surveillance, and survivorship care. However, these varied applications occupy fundamentally different stages of clinical and biolo...

S. K. Kuchana, Nikhilesh V. Alahari, Rohith Kode et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.